Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (261-270 of 335) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2012
European Registry of Carotid Artery Stenting: results from a prospective registry of eight high volume EUROPEAN institutionsEugenio Stabile, Pallav Garg, Alberto Cremonesi, et al.
Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2019
Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-AnalysisThomas A Mavrakanas, Yiannis S Chatzizisis, Karim Gariani, et al.
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
Archives of Internal Medicine|July 11, 2012
Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practiceAmit P Amin, John A Spertus, David J Cohen, et al.
Kardiologia Polska|December 19, 2017
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]Marco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Martin B Leon, David E Kandzari, Eric L Eisenstein, et al.
Journal of the American College of Cardiology|March 20, 2015
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial InfarctionRobert W Yeh, Dean J Kereiakes, Philippe Gabriel Steg, et al.
Pageof 34

Showing results (261-270 of 335) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2012
European Registry of Carotid Artery Stenting: results from a prospective registry of eight high volume EUROPEAN institutionsEugenio Stabile, Pallav Garg, Alberto Cremonesi, et al.
Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2019
Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-AnalysisThomas A Mavrakanas, Yiannis S Chatzizisis, Karim Gariani, et al.
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
Archives of Internal Medicine|July 11, 2012
Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practiceAmit P Amin, John A Spertus, David J Cohen, et al.
Kardiologia Polska|December 19, 2017
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]Marco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Martin B Leon, David E Kandzari, Eric L Eisenstein, et al.
Journal of the American College of Cardiology|March 20, 2015
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial InfarctionRobert W Yeh, Dean J Kereiakes, Philippe Gabriel Steg, et al.
Pageof 34